Peripheral kappa opioid receptors activation reduces alveolar bone loss in rats by modulating interleukin-6 and -10. [electronic resource]
Producer: 20110927Description: 540-8 p. digitalISSN:- 1879-1506
- 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer -- pharmacology
- Alveolar Bone Loss -- prevention & control
- Analysis of Variance
- Animals
- Disease Models, Animal
- Interleukin-10 -- agonists
- Interleukin-6 -- antagonists & inhibitors
- Interleukin-8 -- antagonists & inhibitors
- Male
- Osteoclasts -- drug effects
- Peroxidase -- antagonists & inhibitors
- Rats
- Rats, Sprague-Dawley
- Receptors, Opioid, kappa -- agonists
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.